Mesoblast (MESO) had the highest return between December 1, 2009 and May 31, 2010 by a mid-cap US stock, returning 14,999,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Mesoblast (MESO) | 12/1/2009 - 5/31/2010 | 14,999,900% |
Novanta (NOVT) | 12/1/2009 - 5/31/2010 | 335.94% |
Cirrus Logic (CRUS) | 12/1/2009 - 5/31/2010 | 159.4% |
IDT (IDT) | 12/1/2009 - 5/31/2010 | 154.33% |
American Airlines (AAL) | 12/1/2009 - 5/31/2010 | 134.22% |
Federal Agricultural Mortgage (AGM) | 12/1/2009 - 5/31/2010 | 133.88% |
MGIC Investment (MTG) | 12/1/2009 - 5/31/2010 | 127.73% |
Riot Platforms (RIOT) | 12/1/2009 - 5/31/2010 | 125.45% |
Arrowhead Pharmaceuticals (ARWR) | 12/1/2009 - 5/31/2010 | 125% |
Radian (RDN) | 12/1/2009 - 5/31/2010 | 121.68% |
ChipMOS Technologies (IMOS) | 12/1/2009 - 5/31/2010 | 119.99% |
Astronics (ATRO) | 12/1/2009 - 5/31/2010 | 113.09% |
Nexstar Broadcasting (NXST) | 12/1/2009 - 5/31/2010 | 110.37% |
Crocs (CROX) | 12/1/2009 - 5/31/2010 | 109.94% |
Camtek (CAMT) | 12/1/2009 - 5/31/2010 | 108.8% |
Vera Therapeutics (VERA) | 12/1/2009 - 5/31/2010 | 100% |
Western Alliance Bancorporation (WAL) | 12/1/2009 - 5/31/2010 | 99.75% |
Sanmina (SANM) | 12/1/2009 - 5/31/2010 | 87.12% |
Axos Financial (AX) | 12/1/2009 - 5/31/2010 | 82.74% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 12/1/2009 - 5/31/2010 | 81.68% |
AXT (AXTI) | 12/1/2009 - 5/31/2010 | 81.25% |
Zions Bancorporation (ZION) | 12/1/2009 - 5/31/2010 | 79.97% |
Silicon Motion Technology (SIMO) | 12/1/2009 - 5/31/2010 | 75.67% |
Aurinia Pharmaceuticals (AUPH) | 12/1/2009 - 5/31/2010 | 74.77% |
Brunswick (BC) | 12/1/2009 - 5/31/2010 | 70.44% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.